Groundbreaking GLP-1 drugs like Ozempic, Mounjaro and Wegovy are revolutionising weight loss, with studies showing ...

Luca Maini, assistant professor of health care policy in the Blavatnik Institute at Harvard Medical School, studies ...

A federal judge on Friday said 36 drugmakers and executives must face nearly all claims in an antitrust lawsuit brought by ...

Democrats Got Their Hands on Medicare, It's Never Been the Same Since Seniors shopping for a prescription drug plan during this year's Medicare open ...

During the Medicare annual enrollment period (AEP) for 2026 plans, you can expect changes in premiums and out-of-pocket costs ...

Alnylam Pharmaceuticals, Inc. is rated Hold due to high expectations, competitive threats, and revenue expansion. Learn more ...

The death of former South African minister and ambassador to France, Nathi Mthethwa, has been officially confirmed as a suicide, following revelations that he sent a distressing farewell message to ...

The U.S. Food and Drug Administration announced it will relax certain rules for approving low-cost versions of some high-priced medications to reduce costs.

Wegovy Zepbound cost-effectiveness report finds both drugs remain valuable at higher prices despite affordability concerns, per ICER analysis.

BridgeBio Pharma, Inc.'s Attruby (Acoramidis) delivers early, durable reductions in cumulative cardiovascular events. Learn ...

In Massachusetts, the federal government spends $1.5 billion annually to subsidize health coverage for residents. At the end ...

Oil prices rose $0.82 a barrel Friday morning following reports that the U.S. may strike military targets within Venezuela that the Trump administration associates with drug trafficking. Prices then ...